We shape a sustainable future by making research breakthroughs in and across our disciplines, sparking the game changers of tomorrow and creating novel solutions to major global challenges. Our ...
The THz- and Millimeterwave Techniques group is in search of a doctoral researcher for an interdisciplinary THz medical imaging research program developing diffractive optical elements (DOEs) and ...
Wave is expecting feedback from US regulators on a path forward for WVE-006 as a potential alpha-1 antitrypsin deficiency therapy in mid-2026.
The island nation has officially signed a Memorandum of Understanding (MoU) with Danish firm Wavepiston to turn those ...
A surge of AI data centers is driving up power and water demand across North Carolina, increasing emissions and electricity ...
Apple could benefit from a new wave of NFC technology upgrades after the NFC Forum this week published a roadmap outlining ...
AI systems like Anthropic’s threaten to turn software into a utility, where value shifts away from individual tools and ...
The real story of artificial intelligence is the multi-year progression of capital flows that will define which companies ...
Quantum technologies, devices and systems that process, store, detect, or transfer information leveraging quantum mechanical ...
After GSK’s return of Wave Life Sciences’ WVE-006 as well as the mid-stage failure of Korro Bio’s candidate, the alpha-1 ...
Wave Life Sciences has the fate of its lead RNA editing candidate back in its own hands. | Wave Life Sciences has the fate of its lead RNA editing candidate back in its own hands. GSK has decided not ...
WVE-006 is a first-in-class RNA editing therapeutic candidate designed to correct the root cause of disease for the 200,000 individuals in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results